Jenscare Scientific Co., Ltd. (HKG:9877)
Hong Kong
· Delayed Price · Currency is HKD 9.68
+0.03 (0.31%)
Apr 29, 2026, 4:08 PM HKT
Jenscare Scientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 90.59 | - | - | - | - | Upgrade
|
| Cost of Revenue | 8.07 | - | - | - | - | Upgrade
|
| Gross Profit | 82.52 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 128.44 | 68.18 | 150.31 | 219.7 | 238.51 | Upgrade
|
| Research & Development | 183.61 | 142.64 | 288.15 | 291.58 | 265.34 | Upgrade
|
| Operating Expenses | 312.05 | 210.82 | 438.46 | 511.28 | 503.84 | Upgrade
|
| Operating Income | -229.53 | -210.82 | -438.46 | -511.28 | -503.84 | Upgrade
|
| Interest Expense | -0.87 | -0.29 | -0.14 | -0.11 | -0.13 | Upgrade
|
| Interest & Investment Income | 13.82 | 11.25 | 19.33 | 8.36 | 1.77 | Upgrade
|
| Earnings From Equity Investments | - | - | 18.95 | 16.17 | 1.34 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.91 | 3.17 | 34.62 | -6.84 | Upgrade
|
| Other Non Operating Income (Expenses) | -57.55 | 7.06 | 18.24 | 10.62 | 0.54 | Upgrade
|
| EBT Excluding Unusual Items | -274.12 | -189.89 | -378.92 | -441.62 | -507.16 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.75 | 10.84 | -0.17 | 0.72 | 6.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.04 | -0.09 | -0.01 | -0.01 | - | Upgrade
|
| Asset Writedown | -0.29 | -6.69 | - | - | - | Upgrade
|
| Pretax Income | -272.7 | -185.83 | -379.1 | -440.91 | -500.67 | Upgrade
|
| Earnings From Continuing Operations | -272.7 | -185.83 | -379.1 | -440.91 | -500.67 | Upgrade
|
| Minority Interest in Earnings | 1.48 | 8.32 | 7.36 | 1.6 | 0.16 | Upgrade
|
| Net Income | -271.23 | -177.51 | -371.74 | -439.31 | -500.52 | Upgrade
|
| Net Income to Common | -271.23 | -177.51 | -371.74 | -439.31 | -500.52 | Upgrade
|
| Shares Outstanding (Basic) | 425 | 409 | 417 | 365 | 338 | Upgrade
|
| Shares Outstanding (Diluted) | 425 | 409 | 417 | 365 | 338 | Upgrade
|
| Shares Change (YoY) | 4.02% | -1.97% | 14.17% | 7.96% | 21.43% | Upgrade
|
| EPS (Basic) | -0.64 | -0.43 | -0.89 | -1.20 | -1.48 | Upgrade
|
| EPS (Diluted) | -0.64 | -0.43 | -0.89 | -1.20 | -1.48 | Upgrade
|
| Free Cash Flow | - | -288.81 | -300.64 | -180.14 | -155.17 | Upgrade
|
| Free Cash Flow Per Share | - | -0.71 | -0.72 | -0.49 | -0.46 | Upgrade
|
| Gross Margin | 91.09% | - | - | - | - | Upgrade
|
| Operating Margin | -253.38% | - | - | - | - | Upgrade
|
| Profit Margin | -299.41% | - | - | - | - | Upgrade
|
| EBITDA | -220.33 | -201.62 | -429.68 | -504.82 | -500.44 | Upgrade
|
| EBITDA Margin | -243.23% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 9.2 | 9.2 | 8.78 | 6.46 | 3.41 | Upgrade
|
| EBIT | -229.53 | -210.82 | -438.46 | -511.28 | -503.84 | Upgrade
|
| EBIT Margin | -253.38% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.